Severity
Moderate
ModerateClass IITerminated
FDA Drug recall · Reported December 5, 2012
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
Boehringer Ingelheim Roxane Inc recalled Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by… - a moderate-severity action.
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by… was recalled by Boehringer Ingelheim Roxane Inc in December 5, 2012. Reason: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the qual…. Check the official notice for the remedy. Verify recall #D-067-2013 with the FDA Drug before acting.
The recall
Boehringer Ingelheim Roxane Inc issued this moderate-severity FDA Drug recall-Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the qual….
- Moderate
- severity level
- Class II
- classification
- December 5, 2012
- reported
Sourced from official FDA Drug enforcement records. Verify recall #D-067-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This FDA Drug action (record #D-067-2013) was formally reported on December 5, 2012, with the manufacturer initiating the action on November 5, 2012. It is classified under Moderate severity (Class II), with a current status of Terminated. Boehringer Ingelheim Roxane Inc is listed as the recalling firm, operating out of Columbus, OH. Federal records list the affected scope as 8,381 bottles.
The documented reason for this recall is: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Children & Baby Products recalls over time
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
8,381 bottles
Related Recalls
6
0 from same agency
Product description
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54
Reason for recall
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-067-2013 |
| Date reported | December 5, 2012 |
| Date initiated | November 5, 2012 |
| Recalling firm | Boehringer Ingelheim Roxane Inc |
| Firm location | Columbus, OH |
| Affected scope | 8,381 bottles |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (D-067-2013) and product description against the item you own. Search the archive
- Confirm the current status with FDA Drug before acting, recall details can be updated.
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54. Recalled by Boehringer Ingelheim Roxane Inc. Units affected: 8,381 bottles.
Why was this product recalled? ▼
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on December 5, 2012. Severity: Moderate. Recall number: D-067-2013.
Where was the recalled product distributed? ▼
Distribution: Nationwide.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (D-067-2013) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device? ▼
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
CPSC Moderate
AMASKY Nursing Pillows Recalled Due to Risk of Serious Injury or Death from Suffocation; Violate Mandatory Standards fo…
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
CPSC Moderate
Diamond Wipes International Recalls CVS Health Medicated Hemorrhoidal Wipes Due to Risk of Serious Injury or Death from…
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
CPSC Moderate
Junpower CR2032 Lithium Coin Batteries Recalled Due to Risk of Serious Injury or Death from Battery Ingestion Hazard; V…
· 2026-07-02
CPSC Moderate
Target Recalls Gigglescape™ Under the Sea Popping Toy Due to Choking Hazard
· 2026-07-02
CPSC Moderate
Vevor Recalls Baby Loungers Due to Risk of Serious Injury or Death from Entrapment and Fall Hazards; Violate Mandatory …
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 5, 2012. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.